{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-3006"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-3006","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"Towards Developing GLUT2 Specific Probes for Biochemical and Biomedical Applications","abstract":"Facilitated Glucose transporters (GLUTs) are membrane proteins responsible for the uptake of simple sugars and other structurally similar metabolites in all mammalian cells. One of the hallmarks of cancer is dysfunctional sugar metabolism, known as the Warburg effect, and one of the manifestations of that effect is abnormal GLUT expression. There are 14 known GLUT proteins with different expression patterns in different tissues, and tumors tend to express certain GLUTs that are not present in surrounding healthy tissue. Therefore, selective targeting of GLUTs presents a potentially powerful tool for diagnostics and treatment of cancer and other diseases. This has been an active research area since the 1950s, and recently, selective targeting of GLUT5 was achieved, due to its unique substrate preference. GLUT2 also has a distinct substrate preference, which we attempted to exploit to achieve selective targeting. First, we ran computational models of GLUT2 taking up its highest affinity substrate, glucosamine, to understand which residues play a key role in the substrate recognition and uptake. Next, we screened several fluorescent conjugated glucosamine derivatives in silico to determine the structure activity relationship. And then we synthesized those derivatives in the lab to measure their uptake on live tumor cells that overexpress GLUT2. Those measurements allowed us to verify the validity of our computational model findings and the validity of our hypothesized GLUT2 binding preference, a key step towards achieving GLUT2 selectivity. Additionally, during the glucosamine derivative synthesis process, the limited number of modifications that were possible on existing glucosamine molecules, and the prohibitive cost of other glucosamine-like amino sugars and derivatives inspired the development of a novel viii synthetic pathway to sugars and amino sugars. This synthesis builds the sugar molecule one carbon atom at a time while controlling stereochemistry and substitution, enabling the synthesis of hundreds of possible sugars with different substitution, stereochemistry, and length. The utility of this synthetic approach to sugars potentially extends far beyond the scope of this investigation into GLUT2, and combined with selective targeting of GLUT2, opens the potential for many different biochemical and biomedical applications in the field of oncology and beyond.","abstract_html":"Facilitated Glucose transporters (GLUTs) are membrane proteins responsible for the uptake of simple sugars and other structurally similar metabolites in all mammalian cells. One of the hallmarks of cancer is dysfunctional sugar metabolism, known as the Warburg effect, and one of the manifestations of that effect is abnormal GLUT expression. There are 14 known GLUT proteins with different expression patterns in different tissues, and tumors tend to express certain GLUTs that are not present in surrounding healthy tissue. Therefore, selective targeting of GLUTs presents a potentially powerful tool for diagnostics and treatment of cancer and other diseases. This has been an active research area since the 1950s, and recently, selective targeting of GLUT5 was achieved, due to its unique substrate preference. GLUT2 also has a distinct substrate preference, which we attempted to exploit to achieve selective targeting. First, we ran computational models of GLUT2 taking up its highest affinity substrate, glucosamine, to understand which residues play a key role in the substrate recognition and uptake. Next, we screened several fluorescent conjugated glucosamine derivatives in silico to determine the structure activity relationship. And then we synthesized those derivatives in the lab to measure their uptake on live tumor cells that overexpress GLUT2. Those measurements allowed us to verify the validity of our computational model findings and the validity of our hypothesized GLUT2 binding preference, a key step towards achieving GLUT2 selectivity. Additionally, during the glucosamine derivative synthesis process, the limited number of modifications that were possible on existing glucosamine molecules, and the prohibitive cost of other glucosamine-like amino sugars and derivatives inspired the development of a novel viii synthetic pathway to sugars and amino sugars. This synthesis builds the sugar molecule one carbon atom at a time while controlling stereochemistry and substitution, enabling the synthesis of hundreds of possible sugars with different substitution, stereochemistry, and length. The utility of this synthetic approach to sugars potentially extends far beyond the scope of this investigation into GLUT2, and combined with selective targeting of GLUT2, opens the potential for many different biochemical and biomedical applications in the field of oncology and beyond.","abstract_has_math":false,"creators":["Ismail, Abdelrahman"],"institution":null,"degree_name":"Doctor of Philosophy in Chemistry (PhD)","degree_level":"Open Access Dissertation","degree_discipline":"Department of Chemistry","degree_department":null,"school":null,"contributors":["Marina Tanasova"],"advisors":[],"committee_chairs":[],"committee_members":["Shiyue Fang","Tarun Dam","Smitha Rao"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:19:12Z","subjects":["GLUT2","sugar transporters","sugar synthesis","molecular probes","chemical biology","cancer","Analytical Chemistry","Carbohydrates","Computational Chemistry","Medicinal-Pharmaceutical Chemistry","Organic Chemicals","Organic Chemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/1878"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/1878","href":"https://digitalcommons.mtu.edu/etdr/1878","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/1878","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/1878","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-3006","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Marina Tanasova"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Shiyue Fang","Tarun Dam","Smitha Rao"]},{"key":"dc:creator","label":"Author","values":["Ismail, Abdelrahman"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-01-02T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2025-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy in Chemistry (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["GLUT2","sugar transporters","sugar synthesis","molecular probes","chemical biology","cancer","Analytical Chemistry","Carbohydrates","Computational Chemistry","Medicinal-Pharmaceutical Chemistry","Organic Chemicals","Organic Chemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/1878","https://digitalcommons.mtu.edu/etdr/1878"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Facilitated Glucose transporters (GLUTs) are membrane proteins responsible for the uptake of simple sugars and other structurally similar metabolites in all mammalian cells. One of the hallmarks of cancer is dysfunctional sugar metabolism, known as the Warburg effect, and one of the manifestations of that effect is abnormal GLUT expression. There are 14 known GLUT proteins with different expression patterns in different tissues, and tumors tend to express certain GLUTs that are not present in surrounding healthy tissue. Therefore, selective targeting of GLUTs presents a potentially powerful tool for diagnostics and treatment of cancer and other diseases. This has been an active research area since the 1950s, and recently, selective targeting of GLUT5 was achieved, due to its unique substrate preference. GLUT2 also has a distinct substrate preference, which we attempted to exploit to achieve selective targeting. First, we ran computational models of GLUT2 taking up its highest affinity substrate, glucosamine, to understand which residues play a key role in the substrate recognition and uptake. Next, we screened several fluorescent conjugated glucosamine derivatives in silico to determine the structure activity relationship. And then we synthesized those derivatives in the lab to measure their uptake on live tumor cells that overexpress GLUT2. Those measurements allowed us to verify the validity of our computational model findings and the validity of our hypothesized GLUT2 binding preference, a key step towards achieving GLUT2 selectivity. Additionally, during the glucosamine derivative synthesis process, the limited number of modifications that were possible on existing glucosamine molecules, and the prohibitive cost of other glucosamine-like amino sugars and derivatives inspired the development of a novel viii synthetic pathway to sugars and amino sugars. This synthesis builds the sugar molecule one carbon atom at a time while controlling stereochemistry and substitution, enabling the synthesis of hundreds of possible sugars with different substitution, stereochemistry, and length. The utility of this synthetic approach to sugars potentially extends far beyond the scope of this investigation into GLUT2, and combined with selective targeting of GLUT2, opens the potential for many different biochemical and biomedical applications in the field of oncology and beyond."]},{"key":"dc:title","label":"Title","values":["Towards Developing GLUT2 Specific Probes for Biochemical and Biomedical Applications"]}]}],"canonical_facts":{"dc:contributor":["Marina Tanasova"],"dc:contributor.committeemember":["Shiyue Fang","Tarun Dam","Smitha Rao"],"dc:creator":["Ismail, Abdelrahman"],"dc:date.available":["2026-01-02T08:00:00Z"],"dc:date.created":["2025-01-01T08:00:00Z"],"dc:description.abstract":["Facilitated Glucose transporters (GLUTs) are membrane proteins responsible for the uptake of simple sugars and other structurally similar metabolites in all mammalian cells. One of the hallmarks of cancer is dysfunctional sugar metabolism, known as the Warburg effect, and one of the manifestations of that effect is abnormal GLUT expression. There are 14 known GLUT proteins with different expression patterns in different tissues, and tumors tend to express certain GLUTs that are not present in surrounding healthy tissue. Therefore, selective targeting of GLUTs presents a potentially powerful tool for diagnostics and treatment of cancer and other diseases. This has been an active research area since the 1950s, and recently, selective targeting of GLUT5 was achieved, due to its unique substrate preference. GLUT2 also has a distinct substrate preference, which we attempted to exploit to achieve selective targeting. First, we ran computational models of GLUT2 taking up its highest affinity substrate, glucosamine, to understand which residues play a key role in the substrate recognition and uptake. Next, we screened several fluorescent conjugated glucosamine derivatives in silico to determine the structure activity relationship. And then we synthesized those derivatives in the lab to measure their uptake on live tumor cells that overexpress GLUT2. Those measurements allowed us to verify the validity of our computational model findings and the validity of our hypothesized GLUT2 binding preference, a key step towards achieving GLUT2 selectivity. Additionally, during the glucosamine derivative synthesis process, the limited number of modifications that were possible on existing glucosamine molecules, and the prohibitive cost of other glucosamine-like amino sugars and derivatives inspired the development of a novel viii synthetic pathway to sugars and amino sugars. This synthesis builds the sugar molecule one carbon atom at a time while controlling stereochemistry and substitution, enabling the synthesis of hundreds of possible sugars with different substitution, stereochemistry, and length. The utility of this synthetic approach to sugars potentially extends far beyond the scope of this investigation into GLUT2, and combined with selective targeting of GLUT2, opens the potential for many different biochemical and biomedical applications in the field of oncology and beyond."],"dc:identifier":["10.37099/mtu.dc.etdr/1878","https://digitalcommons.mtu.edu/etdr/1878"],"dc:subject":["GLUT2","sugar transporters","sugar synthesis","molecular probes","chemical biology","cancer","Analytical Chemistry","Carbohydrates","Computational Chemistry","Medicinal-Pharmaceutical Chemistry","Organic Chemicals","Organic Chemistry"],"dc:title":["Towards Developing GLUT2 Specific Probes for Biochemical and Biomedical Applications"],"thesis:degree_discipline":["Department of Chemistry"],"thesis:degree_level":["Open Access Dissertation"],"thesis:degree_name":["Doctor of Philosophy in Chemistry (PhD)"]},"updated_at":"2026-11-19T08:19:12Z"}